Radu Vasilescu

470 total citations
13 papers, 351 citations indexed

About

Radu Vasilescu is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Radu Vasilescu has authored 13 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Hematology and 4 papers in Immunology. Recurrent topics in Radu Vasilescu's work include Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Radu Vasilescu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Radu Vasilescu collaborates with scholars based in Belgium, United States and United Kingdom. Radu Vasilescu's co-authors include José Alvir, M. Tarallo, Peter C. Taylor, Adam Moore, Edward Gibson, Alysia Battersby, Zoltán Vokó, Andrew J.K. Östör, Zoltán Kaló and Tore K Kvien and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Radu Vasilescu

13 papers receiving 345 citations

Peers

Radu Vasilescu

RHEUM

HEMAT

IMMUN

GENET

PFM

Adam Young United Kingdom

Sofia Pazmiño Belgium

Johan K. Wallman Sweden

Jacqueline R. Chipping United Kingdom

Frode Krøll Norway

Joan Von Feldt United States

E. Nikaï United States

S. Kelly United States

Ashwini Shewade United States

S. Al Sawah United States

Adam Young United Kingdom

Radu Vasilescu

362 ×1.4

RHEUM

146 ×1.1

HEMAT

94 ×1.3

IMMUN

52 ×1.0

GENET

64 ×2.1

PFM

Citations per year, relative to Radu Vasilescu Radu Vasilescu (= 1×) peers Adam Young

Countries citing papers authored by Radu Vasilescu

Since Specialization

Citations

This map shows the geographic impact of Radu Vasilescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radu Vasilescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radu Vasilescu more than expected).

Fields of papers citing papers by Radu Vasilescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radu Vasilescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radu Vasilescu. The network helps show where Radu Vasilescu may publish in the future.

Co-authorship network of co-authors of Radu Vasilescu

This figure shows the co-authorship network connecting the top 25 collaborators of Radu Vasilescu. A scholar is included among the top collaborators of Radu Vasilescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radu Vasilescu. Radu Vasilescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Коротаева, Т. В., Oluwaseyi Dina, Elizabeth Holdsworth, et al.. (2021). Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study. Clinical Rheumatology. 40(12). 4915–4926. 7 indexed citations

Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2018). Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice. Patient Preference and Adherence. Volume 12. 2007–2014. 6 indexed citations

Chen, Yi‐Hsing, Umut Kalyoncu, Lyndon Llamado, et al.. (2018). Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. Biologics. Volume 12. 1–9. 7 indexed citations

Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2018). Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment. RMD Open. 4(1). e000615–e000615. 18 indexed citations

Olsen, Inge Christoffer, Elisabeth Lie, Radu Vasilescu, et al.. (2018). Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry. Lara D. Veeken. 58(3). 481–491. 17 indexed citations

Pavelká, Karel, Nurullah Akkoç, Mustafa Al‐Maini, et al.. (2017). Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access. Rheumatology International. 37(9). 1469–1479. 17 indexed citations

Chen, Der‐Yuan, Chak Sing Lau, Bassel Elzorkany, et al.. (2017). Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature. International Journal of Rheumatic Diseases. 21(2). 362–372. 6 indexed citations

Kaló, Zoltán, Zoltán Vokó, Andrew J.K. Östör, et al.. (2017). Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. SHILAP Revista de lepidopterología. 5(1). 1345580–1345580. 36 indexed citations

Taylor, Peter C., Adam Moore, Radu Vasilescu, José Alvir, & M. Tarallo. (2016). A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatology International. 36(5). 685–695. 218 indexed citations

10.

Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2016). 057 Comparison of Biologic Disease-Modifying Anti-Rheumatic Drug Rheumatoid Arthritis Treatment Dynamics Across Five European Union Countries. Lara D. Veeken. 1 indexed citations

11.

Taylor, Peter C., Adam Moore, Radu Vasilescu, José Alvir, & M. Tarallo. (2015). THU0363 A Structured Literature Review of the Burden of Illness and Unmet Needs in Patients with Rheumatoid Arthritis: A Current Perspective. Annals of the Rheumatic Diseases. 74. 327–327. 1 indexed citations

12.

Pavelká, Karel, Nurullah Akkoç, Mustafa Al‐Maini, et al.. (2015). AB0422 Impact of Combination Etanercept-Dmard Induction Therapy in Active Rheumatoid Arthritis: Interim Results of an International Treat-to-Target Study Conducted in Regions with Limited Biologic Access. Annals of the Rheumatic Diseases. 74. 1035–1035. 1 indexed citations

13.

Pavelká, Karel, Zoltán Szekanecz, Nemanja Damjanov, et al.. (2013). Induction of response with etanercept–methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study. Clinical Rheumatology. 32(9). 1275–1281. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact